Eikon Therapeutics, Inc.

SV Health Investors announced the final closing for its second Dementia Discovery Fund, DDF-2, with $269m in commitments from investors and non-profit organizations willing to put their money behind s

Biopharma financing during the first quarter of 2025 totaled $13.1bn from 206 deals. The venture financing category made up the greatest proportion of both the aggregate Q1 financing dollars (46%) and

Included for 2025 are investors, CEOs of small and mid-sized companies, rising employees in larger businesses, and individuals spearheading unique health initiatives worldwide. The 30 individuals list

Venture capital financing for biopharmaceutical companies may be headed into another downturn, reversing a surge in start-up funding that occurred in 2024. New data from Evaluate show that only 109 dr